Found: 1
Select item for more details and to access through your institution.
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 5, p. 763, doi. 10.1002/art.42772
- By:
- Publication type:
- Article